课题基金 / 基金详情

Identification of novel genes that determine cell's sensitivity to anticancer treatments/cell death in malignant tumors of neuronal origin

Identification of novel genes that determine cell's sensitivity to anticancer treatments/cell death in malignant tumors of neuronal origin
确定神经元恶性肿瘤中细胞对抗癌治疗/细胞死亡的敏感性的新基因的鉴定
批准号:
18390389
负责人:
KITANAKA Chifumi
金额:
$5.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KITANAKA Chifumi的其他基金

相似基金

相关文献

中文摘要
翻译
癌细胞即使在充足的氧气中也有以厌氧方式产生能量(=ATP)的倾向,这被称为Warburg效应Warburg效应因此是癌细胞的一种常见表型,并形成了通过18-氟脱氧葡萄糖正电子发射断层扫描(18>18>F]FDG-PET)检测癌症的基础。然而,为什么癌细胞选择严重依赖如此低效的能量产生方式(与有氧能量产生相比效率约1/20)一直是个谜近80年自Warburg效应被发现以来,我们发现有氧能量代谢,而不是无氧能量代谢,在激活Bax和Bak对于线粒体介导的细胞自杀至关重要(Tomiyama,et.等,美国国家癌症研究所98:1462-1473,2006。这篇论文被选为2006年12月出版的《自然·癌症评论》中的一篇《研究亮点》。由于癌细胞与正常细胞不同,不断暴露在各种外部和内部刺激下,导致它们自杀,因此癌细胞需要积极避免自杀才能生存和生长。因此,有了我们的发现,癌细胞的“看似荒谬的能量代谢”现在可以被视为一种以牺牲能源生产效率为代价来避免自杀承诺的“狡猾策略”。我们的发现在癌症治疗学中的另一个重要意义是,如果我们能够将癌细胞的新陈代谢从无氧转变为有氧,那么我们就可以使它们对传统的癌症疗法敏感,这通常依赖于线粒体介导的自杀机制来杀死细胞。在这方面,我们最近发现了一种天然化合物,可以促进胶质母细胞瘤(GBM)细胞的有氧代谢。在未来的项目中,我们将研究这种化合物是否有助于克服GBM细胞固有的治疗耐药性。
英文摘要
Cancer cells have a propensity to produce energy (=ATP) in an anaerobic manner even in the presence of ample oxygen, which is termed Warburg effect Warburg effect is thus a common phenotype of cancer cells and forms a basis for cancer detection by 18-fluorodeoxyglucose positron emission tomography ([^<18>F]FDG-PET) scans. However, why cancer cells choose to rely heavily on such an inefficient way of energy production (〜1/20 efficient compared to aerobic energy production) has remained a mystery for nearly 80 years since the discovery of Warburg effect In this research project, we have discovered that the aerobic energy metabolism, but not the anaerobic one, plays a pivotal role in the activation of Bax and Bak essential for mitochondria mediated cellular suicide (Tomiyama, et. Al., J Natl Cancer Inst 98: 1462-1473, 2006. This paper was selected as a "Research Highlight" in the December issue of Nature Reviews Cancer, 2006). Since cancer cells, unlike normal cells, are continuously exposed to various external and internal stimuli that cause them to commit suicide, cancer cells need to actively avoid suicide to survive and grow. Thus, with our discovery, the "seemingly absurd energy metabolism" of cancer cells can now be viewed as a "crafty strategy" to avoid suicide commitment at the cost of energy production efficiency.Another important implication of our findings in light of cancer therapeutics is that, if we can shift the metabolism of cancer cells from anaerobic to aerobic, then we can sensitize them to conventional cancer therapies, which often depend on the mitochondria mediated suicide mechanism for cell killing. In this respect, we have recently identified a natural compound that promotes aerobic metabolism of glioblastoma (GBM) cells. In the future project, we will be investigating whether this compound is useful in overcoming therapy resistance inherent to GBM cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1523/jneurosci.0341-06.2006
发表时间: 2006-09-06
期刊: JOURNAL OF NEUROSCIENCE
影响因子: 5.3
作者: [Arawaka, Shigeki, Wada, Manabu, Kato, Takeo]
通讯作者: Kato, Takeo
癌細胞自殺の仕組み
癌细胞自杀的机制
DOI: --
发表时间: 2007
期刊: 検査と技術 35
影响因子: --
作者: [立花研, 富山新太, 北中千史]
通讯作者: 北中千史
Role for c-Jun N-terminal kinase(JNK)in Ras-mediated non-apoptotic programmed cell death.
c-Jun N 末端激酶 (JNK) 在 Ras 介导的非凋亡程序性细胞死亡中的作用。
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Mouri, W, et. al.]
通讯作者: et. al.
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Sato A, Sunayama J, Tomiyama A, Tachibana K, Sakurada K, Kayama T, Kitanaka C]
通讯作者: Kitanaka C
共 16 条
    Taking advantage of a pitfall in glioma cancer stem cell epigenetics to develop novel therapies directed to cancer stem cells
    • 批准号:
      16K15640
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    An attempt to answer the cardinal question --- why do cancer cells have such a sweet tooth? --- through glioma stem cell research
    • 批准号:
      15K15522
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    An attempt to create an animal model for glioblastoma cure via proving the hypothesis that glucose metabolism serves as a rheostat to determine the cell fate of cancer stem cells
    • 批准号:
      26670635
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    A daring attempt to cure glioblastoma by targeting glucose metabolism as a novel target to control glioma stem cells
    • 批准号:
      25670615
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      KITANAKA Chifumi
    • 依托单位:
    国内基金
    海外基金
    DJ-1与Calnexin互作调控线粒体—内质网联络区参与帕金森病病理机制的研究
    • 批准号:
      82371414
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      黄沛
    • 依托单位:
    MitoNEET通过调控线粒体形态和功能减轻肾脏缺血再灌注损伤的作用及机制研究
    • 批准号:
      32100537
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      齐元博
    • 依托单位:
    线粒体炫和活性氧信号调控细胞能量代谢平衡的机制研究
    • 批准号:
      92157105
    • 项目类别:
      重大研究计划
    • 资助金额:
      54.0万元
    • 批准年份:
      2021
    • 负责人:
      王显花
    • 依托单位:
    基于超分辨活细胞成像的MDVs形成过程及分子机制的研究
    • 批准号:
      32000480
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      郭玉婷
    • 依托单位: